Eurofins Scientific Se Stock Current Ratio
| ERF Stock | EUR 56.50 1.10 1.91% |
Eurofins Scientific SE fundamentals help investors to digest information that contributes to Eurofins Scientific's financial success or failures. It also enables traders to predict the movement of Eurofins Stock. The fundamental analysis module provides a way to measure Eurofins Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eurofins Scientific stock.
Eurofins |
Eurofins Scientific SE Company Current Ratio Analysis
Eurofins Scientific's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Eurofins Scientific Current Ratio | 1.18 X |
Most of Eurofins Scientific's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eurofins Scientific SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Eurofins Scientific SE has a Current Ratio of 1.18 times. This is 59.45% lower than that of the Healthcare sector and 73.54% lower than that of the Diagnostics & Research industry. The current ratio for all France stocks is 45.37% higher than that of the company.
Eurofins Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eurofins Scientific's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eurofins Scientific could also be used in its relative valuation, which is a method of valuing Eurofins Scientific by comparing valuation metrics of similar companies.Eurofins Scientific is currently under evaluation in current ratio category among related companies.
Eurofins Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.075 | |||
| Current Valuation | 15.18 B | |||
| Shares Outstanding | 192.56 M | |||
| Shares Owned By Insiders | 32.76 % | |||
| Shares Owned By Institutions | 36.72 % | |||
| Price To Earning | 41.19 X | |||
| Price To Book | 2.67 X | |||
| Price To Sales | 1.83 X | |||
| Revenue | 6.72 B | |||
| Gross Profit | 1.42 B | |||
| EBITDA | 1.6 B | |||
| Net Income | 1.06 B | |||
| Cash And Equivalents | 507.98 M | |||
| Cash Per Share | 28.62 X | |||
| Total Debt | 2.08 B | |||
| Debt To Equity | 115.90 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 24.42 X | |||
| Cash Flow From Operations | 1.51 B | |||
| Earnings Per Share | 2.97 X | |||
| Price To Earnings To Growth | 13.92 X | |||
| Target Price | 76.2 | |||
| Number Of Employees | 61 K | |||
| Beta | 0.63 | |||
| Market Capitalization | 12.71 B | |||
| Total Asset | 9.33 B | |||
| Retained Earnings | 159 M | |||
| Working Capital | 651 M | |||
| Current Asset | 1.43 B | |||
| Current Liabilities | 775 M | |||
| Z Score | 3.6 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 0.47 % | |||
| Net Asset | 9.33 B |
About Eurofins Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eurofins Scientific SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eurofins Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eurofins Scientific SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eurofins Scientific in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eurofins Scientific's short interest history, or implied volatility extrapolated from Eurofins Scientific options trading.
Pair Trading with Eurofins Scientific
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eurofins Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eurofins Scientific will appreciate offsetting losses from the drop in the long position's value.Moving against Eurofins Stock
| 0.64 | ALBIO | Biosynex | PairCorr |
| 0.41 | ALMDT | Mediantechn | PairCorr |
The ability to find closely correlated positions to Eurofins Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eurofins Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eurofins Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eurofins Scientific SE to buy it.
The correlation of Eurofins Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eurofins Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eurofins Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eurofins Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eurofins Scientific SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the Eurofins Scientific information on this page should be used as a complementary analysis to other Eurofins Scientific's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Eurofins Stock analysis
When running Eurofins Scientific's price analysis, check to measure Eurofins Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Scientific is operating at the current time. Most of Eurofins Scientific's value examination focuses on studying past and present price action to predict the probability of Eurofins Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Scientific's price. Additionally, you may evaluate how the addition of Eurofins Scientific to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |